FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference

FocalTherics ™ to Present at the H.C. Wain w right 28 th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on T uesday and Wednesday, September 15 th -16 th , 2026 AUSTIN, Texas, Sept.

GlobeNewsWire • Sep 1, 2026

FocalTherics Q2 Earnings Call Highlights

FocalTherics NASDAQ: FOCL reported second-quarter HIFU revenue of $13.2 million, up 39% from $9.5 million a year earlier, as the company continued to expand sales of its Focal One high-intensity focused ultrasound platform for focal therapy.

MarketBeat • Aug 14, 2026

EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript

EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 14, 2026

FocalTherics™ Reports Second Quarter 2026 Financial Results

FocalTherics™ Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced financial results for the second quarter of 2026. This marks the Company's first reporting period presenting its HIFU business as continuing operations and its ESWL and Distribution businesses as discontinued operations.

GlobeNewsWire • Aug 13, 2026

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026

FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026 AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced preliminary unaudited financial results for the Company's HIFU segment, reported as continuing operations, for the second quarter of 2026.  During the second quarter of 2026, the Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution segments met the criteria to be classified as held for sale under ASC 205-20, Presentation of Financial Statements — Discontinued Operations, and ASC 360-10, Property, Plant, and Equipment, and the Company determined that the planned exit represents a strategic shift that will have a significant effect on the Company's operations and financial results.

GlobeNewsWire • Aug 11, 2026

FocalTherics™ Announces Proposed Public Offering of American Depositary Shares

FocalTherics™ Announces Proposed Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ: FOCL) (the “Company”), a global leader in robotic energy-based therapies, announced today that it has commenced an underwritten public offering of American Depositary Shares (“ADSs”), each representing one ordinary share of the Company, €0.13 nominal value per share (the “Offering”). All of the ADSs in the proposed Offering will be sold by the Company.

GlobeNewsWire • Aug 11, 2026

FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares

FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ: FOCL) (the “Company”), a global leader in robotic energy-based therapies, announced the pricing of its underwritten public offering of 8,425,000 of American Depositary Shares (“ADSs”), each representing one ordinary share of the Company, €0.13 nominal value per share at a public offering price of $4.75 per ADS, before underwriting discounts and commissions (the “Offering”). All of the ADSs are being sold by the Company.

GlobeNewsWire • Aug 12, 2026

FocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?

FocalTherics (FOCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research • Aug 5, 2026

FocalTherics™ to Announce Second Quarter 2026 Financial Results on August 13, 2026

Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT Company to host conference call and webcast on Thursday, August 13 at 4:30 p.m. EDT

GlobeNewsWire • Jul 30, 2026

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

GlobeNewsWire • Jun 30, 2026